This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: California Institute of Technology. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Jonathan Cebon
Introduction
Jonathan Cebon is an accomplished inventor based in New York, NY. He has made significant contributions to the field of immunology, particularly in the development of T cell receptors. His work is recognized for its potential impact on cancer therapies.
Latest Patents
Cebon holds a patent titled "Composition of NY-ESO-1-Specific T Cell Receptors Restricted on Multiple Major Histocompatibility Complex Molecules." This patent represents a crucial advancement in the understanding and application of T cell receptors in medical treatments. He has 1 patent to his name.
Career Highlights
Jonathan Cebon is affiliated with the California Institute of Technology, where he continues to engage in groundbreaking research. His work at this prestigious institution has allowed him to explore innovative solutions in the realm of cancer immunotherapy.
Collaborations
Cebon has collaborated with notable colleagues, including Owen N. Witte and Jami McLaughlin Witte. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic approaches.
Conclusion
Jonathan Cebon is a prominent figure in the field of immunology, with a focus on T cell receptor innovations. His contributions are paving the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile